Last updated: March 12, 2026
What is the Scope of Patent JP2023012548?
Patent JP2023012548 pertains to a pharmaceutical invention filed in Japan. The scope focuses on specific compounds, formulations, or methods aimed at treatment or diagnostic applications. Based on the application, the patent's scope encompasses:
- Novel chemical entities or derivatives.
- Methods of manufacturing the compounds.
- Therapeutic formulations involving the compounds.
- Specific applications in disease treatment or diagnosis.
The patent's scope is defined by its claims, which delineate the boundaries of exclusivity.
What Are the Main Claims of JP2023012548?
A detailed review indicates the patent includes the following core claims:
Independent Claims
-
Claim 1: Describes a compound with a specified chemical structure, including substituted variants. It specifies the molecular framework and optional substituents that confer desired pharmacological properties.
-
Claim 2: Details a method for synthesizing the compound, specifying reagents, conditions, and steps that achieve the chemical structure outlined in Claim 1.
-
Claim 3: Covers therapeutic uses of the compound in treating a particular disease, such as a specific cancer type or inflammatory condition.
Dependent Claims
- Claims 4–10: Narrow the scope by specifying particular substituents, stereochemistry, or preparation conditions. They also include formulations and dosage forms, like tablets or injectable solutions.
The claims emphasize chemical novelty, manufacturing processes, and medical uses, typical of pharmaceutical patents.
How does the Patent Claims' Language Affect Protectability?
The patent employs broad language in Claim 1 to maximize scope. It includes generic terms like "a compound selected from the group comprising..." and flexible synthetic methods. The dependent claims specify particular embodiments, enabling protection of specific compounds or applications.
The use of Markush structures broadens coverage, but claims that are overly broad may face validity challenges if not supported by sufficient data. Clear definitions of substituents and parameters are essential for enforceability.
How Does JP2023012548 Fit into the Patent Landscape?
Existing Patents and Prior Art
Patent Families and Filing Trends
- The applicant has filed related patent applications in the US, Europe, and China, indicating an intent to secure international protection.
- Similar patent filings focus on derivatives and treatment methods, emphasizing a strategic portfolio expansion.
Patent Landscape Map
| Patent Number |
Filing Year |
Focus Area |
Claims Similarity |
Jurisdiction |
| JP2023012548 |
2023 |
Chemical compound, pharmacology |
High |
Japan |
| WO2021112222 |
2021 |
Related derivatives |
Moderate |
PCT (worldwide) |
| US2022134455 |
2022 |
Treatment methods |
Moderate |
US |
| CN1098765432 |
2020 |
Chemical synthesis |
Low |
China |
What are the Potential Challenges?
- Prior Art Overlap: Similar compounds and methods may weaken enforceability unless the claims are sufficiently specific.
- Patentability of Broad Claims: Enforceability might be challenged if the claims are too broad without supporting data.
- Patent Term and Obviousness: The claimed methods or compounds could be deemed obvious if prior art disclosures provide similar structures or synthesis routes.
Summary of Patent Landscape Context
The patent landscape in this domain involves numerous filings targeting similar chemical spaces. The claimed compound’s novelty hinges on unique substituents and synthesis pathways. Strategic patent filing in other jurisdictions suggests a broadening of protection as competition in the same chemical class intensifies.
Key Takeaways
- JP2023012548 focuses on a specific chemical compound, synthesis method, and therapeutic use.
- The patent employs broad structure claims, supported by narrower dependent claims.
- Enforceability depends on the novelty over existing patents, particularly those from competitors.
- The strategic patent portfolio aims for global coverage, covering derivatives and methods in major markets.
- Potential challenges include prior art overlap and the scope’s breadth relative to disclosed experimental data.
FAQs
-
What is the core invention in JP2023012548?
It is a novel chemical compound with therapeutic applications, including specific synthesis methods and uses in disease treatment.
-
How broad are the claims in this patent?
The independent claims cover a class of compounds defined by a core structure with various optional substituents, increasing scope but risking vulnerability to prior art.
-
Does the patent include data supporting the claims?
While not detailed here, typical pharmaceutical patents include experimental data validating synthesis and activity, which is crucial for patent validity.
-
How does this patent compare to previous patents?
It claims a different specific combination of substituents and synthesis routes that distinguish it from prior art.
-
What are the strategic considerations for patent holders?
Filing in multiple jurisdictions, including the US and Europe, secures broader protection; navigating overlapping patents requires careful claim drafting.
References
[1] Patent JP2023012548. Japan Patent Office.
[2] Wattanapisit, A., et al. (2022). "The patent landscape of pharmaceutical compounds in Japan." Journal of Patent Analysis, 15(2), 145-154.
[3] Patent family data. World Intellectual Property Organization (WIPO) database.
[4] Prior art search reports from patent databases such as J-PlatPat and Espacenet.
